In vitro biocompatibility of solid lipid nanoparticles

Science of the Total Environment

Volumn 432, Issue , 2012, Pages 382-388

  Silva, Adny Henrique ^a   Filippin Monteiro, Fabíola Branco ^a   Mattei, Bruno ^a   Zanetti Ramos, Betina G ^b   Creczynski Pasa, Tânia Beatiz ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b Nanovetores Encapsulados de Alta Tecnologia   (Brazil)

Author keywords

Cytotoxicity; MDCK cells; SLN; Vero cells

Indexed keywords

CELL LINEAGE; CELL VIABILITY; CELLULAR RESPONSE; CYTOTOXIC; CYTOTOXIC EFFECTS; DNA FRAGMENTATION; FIBROBLAST CELLS; IN-VITRO; IN-VIVO; MDCK CELLS; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL METABOLISM; NANOSCALE STRUCTURE; SLN; SODIUM DODECYL SULFATE; SOLID LIPID NANOPARTICLE (SLN); SOLID LIPID NANOPARTICLES; VERO CELLS;

BIOCOMPATIBILITY; CELL CULTURE; CYTOTOXICITY; FLOW CYTOMETRY; MITOCHONDRIA; SODIUM; SODIUM SULFATE;

NANOPARTICLES;

CELL DNA; DODECYL SULFATE SODIUM; NANOMATERIAL; REACTIVE OXYGEN METABOLITE; SOLID LIPID NANOPARTICLE;

DNA; LIPID; METABOLISM; MITOCHONDRION; PARTICLE SIZE; TOXICITY;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CELL ACTIVITY; CELL ASSAY; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL LINEAGE; CELL POPULATION; CELL STRAIN; CELL VIABILITY; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA FRAGMENTATION; FIBROBLAST; FLOW CYTOMETRY; IC 50; IN VITRO STUDY; LYSOSOME; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; VERO CELL;

ANIMALS; CELL CYCLE; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; DOGS; FIBROBLASTS; FLOW CYTOMETRY; LIPIDS; MADIN DARBY CANINE KIDNEY CELLS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; REACTIVE OXYGEN SPECIES; SPECTROMETRY, FLUORESCENCE; VERO CELLS;

EID: 84862989472     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2012.06.018     Document Type: Article

References (48)

1. Ahamed M. Toxic response of nickel nanoparticles in human lung epithelial A549 cells. Toxicol In Vitro 2011, 25:930-936.
2. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol Rev 1999, 79:1127-1155.
3. Bouaziz C., Abid-Essefi S., Bouslimi A., El Golli E., Bacha H. Cytotoxicity and related effects of T-2 toxin on cultured Vero cells. Toxicon 2006, 48:343-352.
4. Caon T., Zanetti-Ramos B.G., Lemos-Senna E., Cloutet E., Cramail H., Borsali R., et al. Evaluation of DNA damage and cytotoxicity of polyurethane-based nano- and microparticles as promising biomaterials for drug delivery systems. J Nanopart Res 2010, 12:10.
5. Chattopadhyay P., Shekunov B.Y., Yim D., Cipolla D., Boyd B., Farr S. Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system. Adv Drug Deliv Rev 2007, 59:444-453.
6. De Berardis B., Civitelli G., Condello M., Lista P., Pozzi R., Arancia G., Meschini S. Exposure to ZnO nanoparticles induces oxidative stress and cytotoxicity in human colon carcinoma cells. Toxicol Appl Pharmacol 2010, 242:116-127.
7. Dias E., Andrade M., Alverca E., Pereira P., Batoréu M.C., Jordan P., et al. Comparative study of the cytotoxic effect of microcistin-LR and purified extracts from Microcystis aeruginosa on a kidney cell line. Toxicon 2009, 53:487-495.
8. Elzoghby A.O., Samy W.M., Elgindy N.A. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release 2012, 157:168-182.
9. Fadeel B., Garcia-Bennett A.E. Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv Drug Deliv Rev 2010, 62:362-374.
10. Foucaud L., Goulaouic S., Bennasroune A., Laval-Gilly P., Brown D., Stone V., et al. Oxidative stress induction by nanoparticles in THP-1 cells with 4-HNE production: stress biomarker or oxidative stress signalling molecule?. Toxicol In Vitro 2010, 24:1512-1520.
11. Freyre-Fonseca V., Delgado-Buenrostro N.L., Gutiérrez-Cirlos E.B., Calderón-Torres C.M., Cabellos-Avelar T., Sánchez-Pérez Y., et al. Titanium dioxide nanoparticles impair lung mitochondrial function. Toxicol Lett 2011, 202:111-119.
12. Hsiao I.L., Huang Y.J. Effects of various physicochemical characteristics on the toxicities of ZnO and TiO nanoparticles toward human lung epithelial cells. Sci Total Environ 2011, 409:1219-1228.
13. Hu X., Cook S., Wang P., Hwang H.M. In vitro evaluation of cytotoxicity of engineered metal oxide nanoparticles. Sci Total Environ 2009, 407:3070-3072.
14. Ivanova L., Uhlig S. A bioassay for the simultaneous measurement of metabolic activity, membrane integrity, and lysosomal activity in cell cultures. Anal Biochem 2008, 379:16-19.
15. Joshi M.D., Müller R.H. Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm 2009, 71:161-172.
16. Kahru A., Dubourguier H.-C. From ecotoxicology to nanoecotoxicology. Toxicology 2010, 269:105-119.
17. Kayser O., Lemke A., Hernández-Trejo N. The impact of nanobiotechnology on the development of new drug delivery systems. Curr Pharm Biotechnol 2005, 6:3-5.
18. Kwon S.M., Nam H.Y., Nam T., Park K., Lee S., Kim K., et al. In vivo time-dependent gene expression of cationic lipid-based emulsion as a stable and biocompatible non-viral gene carrier. J Control Release 2008, 128:89-97.
19. Liu J., Gong T., Fu H., Wang C., Wang X., Chen Q., et al. Solid lipid nanoparticles for pulmonary delivery of insulin. Int J Pharm 2008, 356:333-344.
20. Martins S., Costa-Lima S., Carneiro T., Cordeiro-da-Silva A., Souto E.B., Ferreira D.C. Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway. Int J Pharm 2012, 430:216-227.
21. Moghimi S.M., Hunter A.C., Murray J.C. Nanomedicine: current status and future prospects. FASEB J 2005, 19:311-330.
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
23. Müller R.H., Runge S., Ravelli V., Mehnert W., Thünemann A.F., Souto E.B. Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals. Int J Pharm 2006, 317:82-89.
24. Nassimi M., Schleh C., Lauenstein H.D., Hussein R., Hoymann H.G., Koch W., et al. A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung. Eur J Pharm Biopharm 2010, 75:107-116.
25. Nel A., Xia T., Mädler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
26. Oberdörster G., Oberdörster E., Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005, 113:823-839.
27. Ormerod M.G. Investigating the relationship between the cell cycle and apoptosis using flow cytometry. J Immunol Methods 2002, 265:73-80.
28. Pardeike J., Hommoss A., Müller R.H. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 2009, 366:170-184.
29. Park E.J., Yi J., Chung K.H., Ryu D.Y., Choi J., Park K. Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells. Toxicol Lett 2008, 180:222-229.
30. Repetto G., del Peso A., Zurita J.L. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nat Protoc 2008, 3:1125-1131.
31. Reuter S., Gupta S.C., Chaturvedi M.M., Aggarwal B.B. Oxidative stress, inflammation, and cancer: how are they linked?. Free Radic Biol Med 2010, 49:1603-1616.
32. Rezzani R., Angoscini P., Borsani E., Rodella L., Bianchi R. Cyclosporine A-induced toxicity in two renal cell culture models (LLC-PK1 and MDCK). Histochem J 2002, 34:27-33.
33. Rico C.M., Majumdar S., Duarte-Gardea M., Peralta-Videa J.R., Gardea-Torresdey J.L. Interaction of nanoparticles with edible plants and their possible implications in the food chain. J Agric Food Chem 2011, 59:3485-3498.
34. Sahay G., Alakhova D.Y., Kabanov A.V. Endocytosis of nanomedicines. J Control Release 2010, 145:182-195.
35. Sauer H., Wefer K., Vetrugno V., Pocchiari M., Gissel C., Sachinidis A., et al. Regulation of intrinsic prion protein by growth factors and TNF-alpha: the role of intracellular reactive oxygen species. Free Radic Biol Med 2003, 35:586-594.
36. Shukla R.K., Sharma V., Pandey A.K., Singh S., Sultana S., Dhawan A. ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells. Toxicol In Vitro 2011, 25:231-241.
37. Spiekstra S.W., Dos Santos G.G., Scheper R.J., Gibbs S. Potential method to determine irritant potency in vitro - comparison of two reconstructed epidermal culture models with different barrier competency. Toxicol In Vitro 2009, 23:349-355.
38. Szabo A., Balog M., Mark L., Montsko G., Turi Z., Gallyas F., et al. Induction of mitochondrial destabilization and necrotic cell death by apolar mitochondria-directed SOD mimetics. Mitochondrion 2011, 11:476-487.
39. Teodoro J.S., Simões A.M., Duarte F.V., Rolo A.P., Murdoch R.C., Hussain S.M., et al. Assessment of the toxicity of silver nanoparticles in vitro: a mitochondrial perspective. Toxicol In Vitro 2011, 25:664-670.
40. Valko M., Rhodes C.J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006, 160:1-40.
41. Vaucher R.A., Teixeira M.L., Brandelli A. Investigation of the cytotoxicity of antimicrobial peptide P40 on eukaryotic cells. Curr Microbiol 2010, 60:1-5.
42. Videira M, Almeida AJ, Fabra A. Preclinical evaluation of a pulmonary delivered paclitaxel-loaded lipid nanocarrier antitumor effect. Nanomed Nanotechnol Biol Med in press. http://dx.doi.org/10.1016/j.nano.2012.12.007.
43. Wang M., Thanou M. Targeting nanoparticles to cancer. Pharmacol Res 2010, 62:90-99.
44. Wang F., Gao F., Lan M., Yuan H., Huang Y., Liu J. Oxidative stress contributes to silica nanoparticle-induced cytotoxicity in human embryonic kidney cells. Toxicol In Vitro 2009, 23:808-815.
45. Wu L., Zhang J., Watanabe W. Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev 2011, 63:456-469.
46. Yang L., Wu S., Zhang Q., Liu F., Wu P. 23,24-Dihydrocucurbitacin B induces G2/M cell-cycle arrest and mitochondria-dependent apoptosis in human breast cancer cells (Bcap37). Cancer Lett 2007, 256:267-278.
47. Yuan H., Zhang W., Du Y.Z., Hu F.Q. Ternary nanoparticles of anionic lipid nanoparticles/protamine/DNA for gene delivery. Int J Pharm 2010, 392:224-231.
48. Zhao M., Antunes F., Eaton J.W., Brunk U.T. Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis. Eur J Biochem 2003, 270:3778-3786.